Wide Ranks

FMS

Fresenius Medical Care AG

22.48

Top Statistics
Market Cap 13 B Forward PE 8.59 Revenue Growth -3.60 %
Current Ratio 1.37 Trailing PE 19.05 Earnings Growth 152.50 %
Profit Margins 3.43 % Peg Ratio Dividend Yield 2.86 %
Enterprice / EBITA 7.29 Enterprise / Revenue 0.9160 Price To Sales Trailing12 Months 0.6857
Profitability
Profit Margins 3.43 % Operating Margins 8.32 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 4.67 Total Debt 11 B
Total Debt To Equity 75.91 Current Ratio 1.37 Book Value Per Share 46.43
All Measures
Short Ratio 311.00 % Message Board Id finmb_384522 Shares Short Prior Month 730178
Return On Equity 0.0582 City Bad Homburg Uuid f13d3c2d-97b7-384c-acb0-6100954459d3
Previous Close 22.11 First Trade Date Epoch Utc 842 M Book Value 46.43
Beta 0.8530 Total Debt 11 B Volume 146767
Price To Book 0.4842 Last Split Date 1 B Fifty Two Week Low 17.93
Total Cash Per Share 4.67 Total Revenue 19 B Shares Short Previous Month Date 1 B
Target Median Price 20.82 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins 8.32 % Last Dividend Value 0.6340 Target Mean Price 21.15
Net Income To Common 658 M Ask 23.17 Implied Shares Outstanding 587 M
Trailing Peg Ratio 45.65 % Last Fiscal Year End 1 B Average Daily Volume10 Day 244160
Average Volume10days 244160 Total Cash 1 B Next Fiscal Year End 1 B
Revenue Per Share 32.78 Ebitda Margins 12.56 % Dividend Rate 0.6400
Trailing PE 19.05 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 22.11 Target Low Price 16.04 Gmt Off Set Milliseconds -18000000
Fifty Day Average 20.90 Open 22.43 Dividend Yield 2.86 %
Free Cashflow 1 B Return On Assets 0.0298 Time Zone Short Name EST
Trailing Eps 1.18 Day Low 22.39 Address1 Else-KrOener-Strasse 1
Trailing Annual Dividend Rate 1.19 Price Hint 2 Shares Outstanding 586 M
Target High Price 29.31 Website https://www.freseniusmedicalcare.com 52 Week Change 0.0961
Average Volume 279057 Earnings Quarterly Growth 152.50 % Forward Eps 2.62
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 79.00 %
Last Split Factor 2:1 Regular Market Day High 22.56 Is_sp_500 False
Profit Margins 3.43 % Debt To Equity 75.91 Fifty Two Week High 22.76
Day High 22.56 Shares Short 1 M Regular Market Open 22.43
Industry Key medical-care-facilities Bid 22.46 Earnings Growth 152.50 %
Enterprise To Revenue 0.9160 Revenue Growth -3.60 % Shares Percent Shares Out 0.0016
Operating Cashflow 2 B Five Year Avg Dividend Yield 130.00 % Currency USD
Market Cap 13 B Time Zone Full Name America/New_York Is_nasdaq_100 False
Zip 61352 Payout Ratio 52.76 % Quote Type EQUITY
Industry Medical Care Facilities Ex Dividend Date 1 B Regular Market Day Low 22.39
Held Percent Institutions 0.0740 Long Name Fresenius Medical Care AG Current Price 22.48
Enterprise To Ebitda 7.29 Financial Currency EUR Trailing Annual Dividend Yield 5.38 %
Current Ratio 1.37 Gross Margins 25.14 % Industry Disp Medical Care Facilities
Number Of Analyst Opinions 6 Country Germany Float Shares 198 M
Two Hundred Day Average 20.17 Enterprise Value 17 B Price To Sales Trailing12 Months 0.6857
Forward PE 8.59 Regular Market Volume 146767 Last Dividend Date 1 B
Ebitda 2 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally.

The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.

In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services.

The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents.

Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.